Evaluation of hospitalisation for patients with anorexia nervosa: Efficacy of treatment and research predictive outcome factors FRESH-PEF60159-en Nathalie GODART Evaluation of hospitalisation for patients with anorexia nervosa: Efficacy of treatment and research predictive outcome factors EVALHOSPITAM OR EVHAN FRESH-PEF60159-en 60159 FRESH-PEF60159 Nathalie GODART COMITE SOCIAL ECONOMIQUE INSTITUT MEDICO-CHIRURGICAL MONTSOURIS (CSE IMM) Epidemiology France Portal (PEF) AGENCE NATIONALE DE LA RECHERCHE (ANR) FONDATION DE FRANCE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) MINISTERE DE L’ENSEIGNEMENT SUPERIEUR, DE LA RECHERCHE ET DE L’ESPACE MINISTERE DE L&#039;EUROPE ET DES AFFAIRES ETRANGERES MINISTERE DU TRAVAIL, DE LA SANTE, DES SOLIDARITES ET DES FAMILLES CNAM null Nathalie;GODART clinical outcome Morgan and Russell scale body mass index menstruation somatic complications psychiatric complications social adjustment treatment received Health episodes mortality Psychiatry Behavioral determinants Behavioral determinants: Eating habits Socio-demographic and economic determinants Behavioral determinants: Addiction General objective: to evaluate the impact (efficacy) of five different inpatient treatment modalities for anorexia nervosa. Individual global health outcome (physical, psychiatric, nutritional and social) will be measured on a short-term basis (on discharge), as well as hospital treatment meeting or exceeding statutory charges on a medium term basis (12 months), taking into account confounding factors and recognised prognostic factors. Global health is evaluated using the Morgan and Russell scale as well as secondary criteria for deteriorating health (see evaluation criteria methodology). Secondary objectives: - to determine predictive factors for failures in inpatient treatment, duration of hospitalisation, and treatment costs using clinical epidemiology methodology. - to begin a long-term prospective study to evaluate the psychological, physical, nutritional and social outcome of a homogeneous cohort of subjects suffering from severe anorexia nervosa. - two "ancillary" biological sub-projects: - to evaluate the development of depressive and anxiety symptoms in relation to changes in clinical nutritional status and serotonin markers - to evaluate cellular immunity development in relation to changes in clinical nutrition. null France Individuals Patients population Male Female Child (6 to 12 years) Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Patients between 8 and 65 years old; - patients hospitalised for anorexia nervosa (who only receive treatment by necessity of somatic condition: rapid weight loss, or significantly underweight with a BMI of less than 15, or their psychological condition), as well as parents of minor and adult patients still living at home; - obtained written consent; - patients not covered by social security health insurance. Participant-reported health data Biological data Health event/morbidity Health event/mortality Other Through organizations (health services or institutions schools businesses etc.) < 500 individuals Self-administered questionnaire Interview with the participant (including clinical) Observational Study Observational Study 180 Unknown Restricted access To be decided if data may be used by academic teams. Data may not be used by industrial teams. Access on specific project only